Groundbreaking research presented at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo has revealed how transgender hormone therapy affects the results of common laboratory tests in the long term. This first-of-its-kind study could enable the development of transgender-specific reference intervals, which are crucial to ensuring that transgender patients get accurate diagnoses and equitable healthcare.
“New research in rats suggests the possibility of bioengineering artificial ovaries in the lab to provide a safer, more natural hormone replacement therapy for women…”
Back to the hospital. Second time in 48 hours.
I think it’s time to find some answers. Hopefully the doctors will agree.
“The use of PrEP is growing but how well it protects is still being observed, especially in transgender and gender nonconforming individuals. The simple fact that transgender people have been excluded from past testing makes collecting important data extremely difficult. Only recently, have studies started changing how trans people, especially trans women are viewed and identified. In the past, transgender women were once placed in the MSM category (men that have sex with men) which didn’t settle well with them. Due to this, many were left untreated and refused to be a part of research because of how they were classified. However, studies and categories are changing and now transgender people and the use of PrEP is being recognized more often. How and if hormones affect the drug is the primary focus and placing trans people within their own category is important because of the percentage of people on Hormone Replacement Therapy (HRT).”
“The 6th Annual Transgender Medical Symposium occurred in May in Fort Lauderdale. This free event drew 140 people. The two-day symposium discussed many medical and mental health issues that the transgender community faces.
(Via. South Florida Gay News)
“The discovery of a genetic variation in male to female transsexuals adds weight to the view that transsexualism has a biological basis, the Australian researchers behind the find say.
Their study shows male to female transsexuals are more likely than non-transsexual males to have a longer version of a receptor gene for the sex hormone androgen or testosterone.
The findings from the largest-yet genetic study of male to female transsexualism are published online today in Biological Psychiatry.”
“Small survey reveals lack of knowledge about these patients”